Backing the Future of Global Biotech: Reynold Lemkins’ Strategy Across Borders and Stages
Reynold Lemkins Group, an international investment firm focused on value-driven cross-border capital deployment, announced the continued advancement of its strategic focus in late-stage healthcare, AI-powered therapeutics, and Asia-centered biotech commercialization.
